Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · IEX Real-Time Price · USD
11.74
+0.46 (4.08%)
At close: Jul 26, 2024, 4:00 PM
11.54
-0.20 (-1.70%)
After-hours: Jul 26, 2024, 6:35 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $687.20 million as of July 26, 2024. Its market cap has increased by 5.32% in one year.
Market Cap
687.20M
Enterprise Value
814.68M
1-Year Change
5.32%
Ranking
Category
Stock Price
$11.74
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $636.70M to $687.20M, an increase of 7.93%. That is a compound annual growth rate of 1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 660.30M | 26.32% |
| Dec 29, 2023 | 522.70M | 11.93% |
| Dec 30, 2022 | 467.00M | -24.42% |
| Dec 31, 2021 | 617.90M | -35.78% |
| Dec 31, 2020 | 962.20M | 25.98% |
| Dec 31, 2019 | 763.80M | 19.96% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 685.65M |
| UroGen Pharma | 682.80M |
| REGENXBIO | 681.95M |
| SI-BONE | 681.94M |
| Acelyrin | 676.35M |
| Ginkgo Bioworks Holdings | 673.41M |
| Prime Medicine | 664.97M |
| Pediatrix Medical Group | 663.08M |